•  Bayer has introduced the new Bepanthen Derma range for the first time in KSA, featuring a high concentration of natural ingredients and an innovative new formula to repair skin from within.
  • The launch event was attended by key opinion leaders in the medical field and Nancy Ajram as leading brand ambassador.

Jeddah – Ba yer has announced the launch of a new dermatologically-tested skincare range in the Kingdom of Saudi Arabia (KSA) targeting sensitive and dry skin conditions. The new Bepanthen Derma range has been developed by Bayer for the face and body, comprising of both moisturizers and cleansers for day and night.

The announcement was made today during a launch event among top dermatology experts and key opinion leaders, including Dr. Sameer Zimmo, Chairman of the Department of Dermatology and King Abdulaziz University, Prof. Thomas Luger from the Department of Biomedical Science at Malmo University in Sweden, and Prof. Enzo Berardesca from the San Gallicano Dermatological Institute in Rome. The second day of the launch event also welcomed Nancy Ajram as the leading brand ambassador and guest of honor.

Formulated with pharma grade skin healing science, the range contains a unique combination of ingredients including Dexpanthenol and Niacinamide that work deep within the skin to treat the root cause of dryness, restoring it from the inside out. It is a clinically proven formula with the ability to repair the disrupted cell renewal process.

Based on research[1], 56% of women in the Middle East are reported to suffer from dry to very dry skin, making it a significant skin health issue to manage in the region. As a highly emergent market in the Middle East, Bayer is committed to making the highest quality derma solutions available at every pharmacy and over-the-counter convenience stores in the Kingdom.

Commenting on the significance of this launch Mohamed Galal, Vice President, Head of Middle East, Bayer Consumer Health, said, "At Bayer, we firmly believe in our purpose to drive science for a better life. The Bepanthen Derma launch stems from the company’s unyielding commitment to providing all consumers a wide range of essential products in the Kingdom of Saudi Arabia to manage their personal health.”

“Our skin is not only what protects us but connects us to the world and the people we love. That is why we sought to develop an innovative formula that is not only effective but gentle and created in close collaboration with dermatologists. We are especially proud of the milestone this represents for Bayer Consumer Health, as KSA will be the first market in the region to receive these products.”

Hesham El Khouly, Commercial Lead of Bayer Consumer Health – KSA, said, “In our market research, we noted that many women in the region are forced to manage pervasive dry skin conditions throughout the year, affecting their overall quality of life. This pointed us to a clear need for an affordable, effective skincare solution among women in KSA that can address their concerns. By offering a formulation with a 90% concentration of natural ingredients, we have ensured that we are listening to today’s health conscious, connected skincare audience.”

The launch of the Bepanthen Derma range marks the latest milestone for a brand that has been perfecting skincare solutions for over 75 years. The new range consists of eight new upgraded products for the whole family including face creams, body lotions and cleansers that prioritize the use of natural ingredients while keeping its formulation free of preservatives, fragrance, and coloring.

-Ends-

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability, and quality throughout the world. In fiscal 2020, the Group employed around 100,000 people and had sales of 41.4 billion euros. R&D expenses before special items amounted to 4.9 billion euros. For more information, go to www.bayer.com.

Contact: 
Sami Joost
Head of Communications / Public Affairs, Science & Sustainability (PASS) – Middle East
Email: sami.joost@bayer.com
For Medical Information: med-info.me@bayer.com
For Safety Reporting: pv.me@bayer.com
Find more information at www.bayer.com.
This PRL is being issued by Hill+Knowlton Strategies on behalf of Bayer, for further information please contact:
Maggie El Eid
Senior Account Executive
Email: maggie.eleid@hkstrategies.com

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.